Categories AlphaGraphs, Earnings, Technology

Infographic: Highlights of General Electric’s Q1 2022 earnings

General Electric Company (NYSE: GE) reported a sharp increase in first-quarter adjusted earnings despite flat revenues. The numbers came in above analysts’ forecast, driving the company’s stock higher in early trading on Tuesday.

General Electric Company Q1 2022 earnings infographic

The engineering conglomerate posted adjusted earnings of $0.24 per share for the March quarter, up from the $0.13 per share profit it reported in the comparable quarter of 2021. The latest number also exceeded experts’ projections. On an unadjusted basis, it was a net loss of $0.74 per share, compared to earnings of $0.02 per share in the prior-year period.

First-quarter revenues came in at $17.0 billion, which is broadly unchanged from the prior-year level. Analysts were looking for a slightly smaller number for the most recent quarter.


Check this space for management/analysts’ comments on General Electric’s Q1 2022 earnings


“We’re holding the outlook range we shared in January, but as we continue to work through inflation and other evolving pressures, we’re currently trending toward the low end of the range. Importantly, we remain on track to launch three independent, investment-grade companies with leading positions in growing, critical sectors, well-positioned to create long-term value,” said Lawrence Culp, Jr., chief executive officer of GE.

Prior Performance

  • General Electric company Q1 2021 earnings

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top